Mycoplasma Genitalium in the Far North Queensland Backpacker Population: An Observational Study of Prevalence and Azithromycin Resistance

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Aug 29

PMID 30153259

Citations 4

Authors

Thomas Trevis

Marianne Gosse

Nicola Santarossa

Sepehr Tabrizi

Darren Russell

William John McBride

Affiliations

Soon will be listed here.

Abstract

Background: Mycoplasma genitalium is a sexually transmitted infection (STI), and a common cause of non-gonococcal urethritis (NGU). There is concern regarding the rise in prevalence of M. genitalium and rates of resistance to macrolide antibiotics. International backpackers represent a unique population that may be at an increased risk of STIs. The purpose of this study was to determine the prevalence of M. genitalium and antibiotic resistance in international backpackers.

Methods: First void urine samples were obtained utilising opportunistic sampling from 294 non-treatment-seeking international backpackers at a variety of hostels in Cairns, Queensland Australia. Participants also answered a fixed-answer survey regarding sociodemographic characteristics and sexual risk behaviours. Samples were tested for M. genitalium, Chlamydia trachomatis and Neisseria gonorrhoeae using polymerase chain reaction (PCR). Samples positive for M. genitalium were investigated for macrolide resistance-associated mutations in the 23S rRNA genome at positions A2058G, A2058C, A2058T, A2059G and A2059C (Escherichia coli numbering).

Results: Of the 294 samples, 23 failed the internal control. The prevalence of M. genitalium was 1.8% (5/271, 95% confidence interval [CI] ± 1.58), C. trachomatis was 4.1% (11/271, 95% CI ± 2.36) and N. gonorrhoeae was not detected. Macrolide resistance-associated mutations were identified in 40% (2/5) of M. genitalium-positive samples. M. genitalium infection was associated with reporting symptoms (odds ratio [OR] 14.36, 95% CI 2.17-94.94, p < 0.05).

Conclusions: M. genitalium and C. trachomatis are relatively common amongst non-treatment seeking international backpackers, but may not differ from Australian population prevalence. This article provides evidence to further support the increased utilisation of M. genitalium PCR in the diagnosis of NGU, and for macrolide resistance testing for all identified M. genitalium infections.

Citing Articles

A systematic review and meta-analysis of sexually transmitted infections and blood-borne viruses in travellers.

Shiferaw W, Martin B, Dean J, Mills D, Lau C, Paterson D J Travel Med. 2024; 31(4).

PMID: 38438164 PMC: 11149723. DOI: 10.1093/jtm/taae038.

Emergence and Mechanism of Resistance of Tulathromycin Against in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants.

Xia X, Yang L, Ling Y, Yu J, Ding H Front Vet Sci. 2022; 9:801800.

PMID: 35224081 PMC: 8873822. DOI: 10.3389/fvets.2022.801800.

[Mycoplasma genitalium in Primary Care: Prevalence and azithromycin resistance in Santiago de Compostela Health Care Area].

Trevino M, Rodriguez-Velasco M, Manso T, Cea M Rev Esp Quimioter. 2021; 34(5):496-499.

PMID: 34286949 PMC: 8638832. DOI: 10.37201/req/052.2021.

Levels of Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines.

Sweeney E, Trembizki E, Bletchly C, Bradshaw C, Menon A, Francis F J Clin Microbiol. 2019; 57(3).

PMID: 30602443 PMC: 6425175. DOI: 10.1128/JCM.01555-18.

References

Ona S, Molina R, Diouf K . Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?. Infect Dis Obstet Gynecol. 2016; 2016:4513089. PMC: 4860244. DOI: 10.1155/2016/4513089. View

Horner P, Thomas B, Gilroy C, Egger M, Taylor-Robinson D . Do all men attending departments of genitourinary medicine need to be screened for non-gonococcal urethritis?. Int J STD AIDS. 2002; 13(10):667-73. DOI: 10.1258/095646202760326408. View

Zheng H, Xue Y, Bai S, Qin X, Lu P, Yang B . Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure. Sex Transm Dis. 2015; 42(3):115-9. DOI: 10.1097/OLQ.0000000000000241. View

Lis R, Rowhani-Rahbar A, Manhart L . Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015; 61(3):418-26. DOI: 10.1093/cid/civ312. View

Whiley D, Buda P, Bayliss J, Cover L, Bates J, Sloots T . A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene. Eur J Clin Microbiol Infect Dis. 2004; 23(9):705-10. DOI: 10.1007/s10096-004-1170-0. View

Horner P, Blee K, Adams E . Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!. Curr Opin Infect Dis. 2013; 27(1):68-74. DOI: 10.1097/QCO.0000000000000030. View

Manhart L, Broad J, Golden M . Mycoplasma genitalium: should we treat and how?. Clin Infect Dis. 2011; 53 Suppl 3:S129-42. PMC: 3213402. DOI: 10.1093/cid/cir702. View

Bradshaw C, Chen M, Fairley C . Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One. 2008; 3(11):e3618. PMC: 2572837. DOI: 10.1371/journal.pone.0003618. View

Manhart L . Mycoplasma genitalium: An emergent sexually transmitted disease?. Infect Dis Clin North Am. 2013; 27(4):779-92. DOI: 10.1016/j.idc.2013.08.003. View

10.

Couldwell D, Lewis D . Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations. Infect Drug Resist. 2015; 8:147-61. PMC: 4454211. DOI: 10.2147/IDR.S48813. View

11.

Bavastrelli M, Midulla M, Rossi D, Salzano M, Calzolari E, Midulla C . Sexually active adolescents and young adults: a high-risk group for Chlamydia trachomatis infection. J Travel Med. 1998; 5(2):57-60. DOI: 10.1111/j.1708-8305.1998.tb00464.x. View

12.

Sena A, Lensing S, Rompalo A, Taylor S, Martin D, Lopez L . Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis. 2012; 206(3):357-65. PMC: 3490700. DOI: 10.1093/infdis/jis356. View

13.

Couldwell D, Tagg K, Jeoffreys N, Gilbert G . Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS. 2013; 24(10):822-8. DOI: 10.1177/0956462413502008. View

14.

Davies S, Shepherd B, Wiig R, Kaan I . Unsupervised screening for chlamydia and gonorrhoea in backpacker hostels in Manly, Sydney. Sex Health. 2012; 10(2):185-7. DOI: 10.1071/SH12136. View

15.

Horner P, Blee K, OMahony C, Muir P, Evans C, Radcliffe K . 2015 UK National Guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2015; 27(2):85-96. DOI: 10.1177/0956462415586675. View

16.

Ansart S, Hochedez P, Perez L, Bricaire F, Caumes E . Sexually transmitted diseases diagnosed among travelers returning from the tropics. J Travel Med. 2009; 16(2):79-83. DOI: 10.1111/j.1708-8305.2008.00279.x. View

17.

Leung A, Eastick K, Haddon L, Horn C, Ahuja D, Horner P . Mycoplasma genitalium is associated with symptomatic urethritis. Int J STD AIDS. 2006; 17(5):285-8. DOI: 10.1258/095646206776790231. View

18.

Horner P, Taylor-Robinson D . Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis. Sex Transm Infect. 2010; 87(1):38-40. DOI: 10.1136/sti.2010.044487. View

19.

Davies S, Karagiannis T, Headon V, Wiig R, Duffy J . Prevalence of genital chlamydial infection among a community sample of young international backpackers in Sydney, Australia. Int J STD AIDS. 2011; 22(3):160-4. DOI: 10.1258/ijsa.2010.010354. View

20.

Tagg K, Jeoffreys N, Couldwell D, Donald J, Gilbert G . Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol. 2013; 51(7):2245-9. PMC: 3697725. DOI: 10.1128/JCM.00495-13. View